Merrimack pharmaceuticals inc (MACK)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11
Assets
Current assets:
Cash and cash equivalents

18,025

16,580

20,858

36,917

36,542

20,079

49,794

22,460

34,268

93,441

107,245

135,501

17,155

21,524

36,463

21,491

48,237

185,606

56,350

33,664

28,833

35,688

100,323

77,751

66,897

65,086

105,451

30,943

28,435

37,714

27,909

32,043

30,555

50,454

Restricted cash

-

-

-

-

-

-

-

-

-

-

102

102

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

2,987

21,924

51,199

35,052

37,544

41,998

-

-

-

-

-

12,003

61,176

84,153

-

6,000

33,991

62,938

88,340

53,356

14,995

57,279

90,116

77,034

31,197

58,252

72,238

58,759

74,669

-

-

Restricted cash

-

-

-

584

584

584

584

-

-

102

-

-

102

102

102

101

101

101

101

101

101

101

101

101

101

101

101

100

100

100

100

100

100

-

Accounts receivable, net

-

-

-

-

-

-

-

-

-

100

190

43

43

275

22,170

19,325

15,637

11

2,051

1,762

4,248

3,313

2,568

6,605

12,155

5,857

8,835

14,537

9,798

9,267

6,054

6,940

5,980

7,426

Inventory

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,770

12,321

8,083

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,631

1,946

Prepaid expenses and other current assets

1,947

2,112

1,540

2,069

4,644

4,240

1,837

1,727

844

1,403

8,040

5,917

2,338

2,239

4,109

4,619

4,470

4,214

6,419

5,366

3,178

4,623

5,795

4,396

2,450

5,484

8,860

9,170

10,167

8,982

11,259

6,570

6,526

5,763

Assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

26,634

33,295

-

-

-

11,462

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

19,972

18,692

22,398

42,557

63,694

76,102

87,267

61,731

77,110

95,046

115,577

141,563

46,272

57,435

89,617

119,033

160,681

201,394

70,921

74,884

99,298

132,065

162,143

103,848

138,882

166,644

200,281

85,947

106,752

128,301

104,081

120,322

45,792

65,589

Restricted cash

-

-

-

-

-

-

-

-

-

-

60,682

60,682

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

584

674

674

-

-

674

674

674

674

584

584

584

584

584

584

584

584

584

584

583

567

528

528

381

381

381

381

Property and equipment, net

-

-

-

-

1,009

2,269

3,188

4,143

5,358

6,467

10,188

11,178

12,852

14,212

17,564

19,614

20,824

20,101

19,964

18,273

15,749

14,502

14,313

13,731

13,779

13,364

11,468

8,155

7,307

6,297

4,834

5,040

5,232

6,206

Equity method investment

-

-

-

-

7,127

7,428

8,893

9,134

9,805

10,551

11,400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

1,369

1,390

2,443

2,483

2,523

2,744

4,568

4,634

4,548

4,588

-

27

27

27

27

27

27

27

125

132

139

25

152

160

167

175

181

31

34

1,068

1,055

23

23

23

Intangible assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,922

7,066

7,211

2,800

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

8,814

9,135

-

-

-

9,974

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,285

1,365

1,445

7,725

1,605

1,685

1,765

1,845

1,925

2,005

2,085

2,165

2,245

2,325

2,405

2,485

In-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,200

6,200

6,200

-

6,200

6,200

6,200

6,200

6,200

7,010

7,010

7,010

7,010

7,010

7,010

7,010

Goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,605

3,605

3,605

-

3,605

3,605

3,605

3,605

3,605

3,605

3,605

3,605

3,605

3,605

3,605

3,605

3,605

3,605

3,605

3,605

Total assets

21,341

20,082

24,841

45,040

74,353

88,543

103,916

80,226

97,495

117,326

197,847

213,450

68,639

81,483

118,409

150,019

192,932

234,880

102,684

105,043

127,020

158,506

188,602

129,813

164,982

192,417

224,243

107,320

127,321

148,974

123,211

138,706

64,448

85,299

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable, accrued expenses and other

3,240

2,714

4,683

4,940

10,339

13,677

19,049

15,569

15,323

17,606

23,983

33,989

38,756

28,670

49,699

44,796

50,449

36,739

38,702

46,626

42,979

37,236

35,989

32,208

34,110

38,814

42,913

36,322

31,184

25,644

-

-

-

17,511

Note payable

-

-

-

-

1,475

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued intraperiod tax allocation

-

-

-

-

-

-

1,340

-

-

-

6,613

13,530

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

771

2,745

2,599

-

Accrued expenses and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,759

14,113

-

-

Dividends payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

88

261

-

-

Capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

48

Deferred revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36,610

44,157

45,097

-

55,072

59,346

59,506

59,275

68,737

46,283

9,527

9,336

9,336

9,336

8,890

9,350

8,764

8,562

8,245

7,712

Deferred rent

-

-

-

-

-

1,118

1,676

2,325

2,211

2,171

2,117

2,077

2,054

2,014

1,974

1,935

1,817

1,527

1,488

1,582

1,224

1,285

1,282

1,310

1,330

1,336

-

-

1,243

1,153

1,295

115

135

125

Income taxes payable

-

-

-

-

-

-

-

-

-

-

1,844

8,141

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liabilities held for sale

-

-

-

-

-

-

-

-

-

-

-

-

67,187

57,538

-

-

-

65,480

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term debt, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,058

-

13,315

15,227

11,052

12,022

8,248

-

-

-

2,373

-

-

-

-

Deferred tax incentives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

512

-

512

876

755

755

Derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

231

-

-

-

-

-

Loans payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,376

9,970

6,254

-

-

-

-

-

Other current liability

56

56

56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,234

2,119

-

-

-

-

13,061

-

Total current liabilities

3,296

2,770

4,739

4,940

11,814

14,795

22,065

17,894

17,534

19,777

34,557

57,737

107,997

88,222

88,283

90,888

97,363

103,746

95,262

108,612

103,709

111,111

121,235

90,853

56,989

57,734

60,859

57,747

48,314

38,520

28,189

26,672

24,805

26,151

Deferred revenues, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36,328

39,900

47,103

-

13,963

9,109

23,229

35,682

56,264

3,023

64,110

66,139

66,390

68,724

68,509

71,114

74,980

77,736

80,862

78,033

Deferred rent, net of current portion

-

-

-

-

-

-

-

-

651

1,209

1,772

2,330

2,868

3,386

3,905

4,423

4,832

4,926

5,356

5,652

5,156

5,401

5,710

5,987

6,266

6,538

-

-

6,735

6,323

6,140

202

231

23

Note payable, net of discount

-

-

-

-

13,519

14,873

14,752

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax incentives, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

165

822

934

1,045

1,307

417

468

496

629

740

424

507

-

-

627

755

883

1,011

1,199

1,267

Long-term debt, net of current portion

-

-

-

-

-

-

-

-

-

-

49,884

48,906

218,041

216,861

216,871

215,544

259,843

257,655

126,261

123,117

122,080

106,687

103,428

105,135

101,789

103,427

-

-

-

37,482

-

-

-

-

Long-term liabilities held for sale

-

-

-

-

-

-

-

-

-

-

-

-

16,877

25,673

-

-

-

51,197

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible preferred stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

957

1,516

Loans payable, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,379

30,592

34,076

-

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,200

1,200

1,200

1,200

1,200

1,200

1,200

1,200

1,200

1,200

1,200

1,200

-

-

-

-

Other long-term liabilities

-

-

-

56

56

56

56

56

56

56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,476

7,398

-

-

-

-

-

-

4.50% convertible senior notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

70,574

-

-

-

-

-

-

-

Total liabilities

3,296

2,770

4,739

4,996

25,389

29,724

36,873

17,950

18,241

21,042

86,213

108,973

345,783

334,142

345,552

351,577

410,075

418,569

243,349

248,107

255,842

260,577

288,466

206,938

230,778

235,545

240,878

165,661

159,461

155,394

110,192

105,621

108,054

106,990

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-2,031

-1,406

-1,539

-361

-154

54

239

481

273

396

69

-150

-

-

337

-

-

-

-

-

-

-

-

Non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13

168

-

-

-

-

97

-

-

-

-

Convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

268,225

Convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

268,225

-

Non-controlling interest (deficit)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-374

-242

-73

-

222

343

456

574

Stockholders’ equity:
Preferred stock, $0.01 par value: 10,000 shares authorized at March 31, 2020 and December 31, 2019; no shares issued or outstanding at March 31, 2020 or December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.01 par value: 30,000 shares authorized at March 31, 2020 and December 31, 2019; 13,380 shares issued and outstanding at March 31, 2020 and December 31, 2019

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,328

1,327

1,319

1,302

1,294

1,290

1,164

1,159

1,151

1,108

1,094

1,067

1,057

1,045

1,034

1,025

1,023

964

959

958

940

935

119

118

Additional paid-in capital

557,071

556,587

562,638

581,875

581,365

580,771

580,047

579,265

578,485

577,721

580,126

578,103

707,428

702,377

693,449

-

-

617,145

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

688,760

622,358

-

612,110

567,754

559,175

552,037

545,112

539,785

532,840

527,779

522,714

441,293

437,263

434,679

429,195

426,005

61,717

60,231

Accumulated other comprehensive loss

-

-

-

-

-

-9

-5

-1

-12

-

-

-

-

-

-2

1

-14

-

-

-6

-27

-74

-43

-3

-8

-24

-16

-5

-20

-38

10

-49

-

-

Accumulated deficit

-540,360

-540,609

-543,870

-543,165

-533,735

-523,277

-514,333

-518,322

-500,553

-482,771

-469,820

-472,922

-984,485

-954,799

-921,523

-891,455

-840,705

-802,232

-754,407

-712,193

-689,460

-655,170

-645,840

-617,939

-599,830

-572,245

-539,982

-500,351

-470,269

-442,116

-417,348

-394,149

-374,123

-350,839

Total stockholders’ equity

18,045

17,312

20,102

40,044

48,964

58,819

67,043

62,276

79,254

96,284

111,634

106,508

-275,738

-251,120

-226,782

-201,404

-217,197

-183,928

-141,146

-143,337

-129,218

-102,140

-99,714

-77,112

-65,964

-43,465

-16,261

-58,099

-32,067

-6,517

12,797

-

-

-290,490

Total stockholders' (deficit) equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32,742

-312,287

-

Total liabilities and stockholders’ equity

21,341

20,082

24,841

45,040

74,353

88,543

103,916

80,226

97,495

117,326

197,847

213,450

68,639

81,483

118,409

150,019

192,932

234,880

102,684

105,043

127,020

158,506

188,602

129,813

164,982

192,417

224,243

107,320

127,321

148,974

123,211

138,706

64,448

85,299